Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
PURPOSE: We aimed to identify key midlife dementia predictors and develop a novel machine learning (ML) -enabled risk prediction model. METHODS: Using data from 9,266 Atherosclerosis Risk in Communities study participants (aged 45-64 years at baseline, 1987-1989). Incident dementia was ascertained through December 2019. A ML-based LASSO-Cox model was applied to develop the risk prediction model. R...
BACKGROUND: Alzheimer's disease (AD) and dementia pose a significant clinical and economic burden globally. Early diagnosis and intervention can potentially delay disease progression. Current diagnostic guidelines recommend considering imaging and biomarker analysis in conjunction with clinical evaluation. Given limited healthcare resources, evidence on the cost-effectiveness of diagnostic technol...
Alzheimer's disease (AD) remains a major global health challenge, with current therapies offering only symptomatic relief. A significant constraint in...
To examine the relationship between artificial intelligence (AI) and older adults with chronic diseases a scoping review methodology was used. Using f...
High consumption of colorful fruits and vegetables correlates with low dementia risk, but the exact molecules and the underlying biological mechanisms...
In this study, a series of thirty-five novel imidazolium salts bearing a 2-oxindoles were designed and synthesized as potent acetylcholinesterase (ACh...
BACKGROUND: Transthyretin amyloid cardiomyopathy (ATTR-CM) causes a restrictive cardiomyopathy resulting in heart failure (HF). Signaling pathways ass...
BACKGROUND: Postacute care (PAC) services are important to ensure functional recovery and provide adequate care for geriatric inpatients in acute care...
Chlamydia pneumoniae is an intracellular bacterium implicated in Alzheimer's disease (AD), but its role in retinal pathology and disease progression i...
Intelligent decision-making systems using wearable electronics and deep learning (DL) might identify Alzheimer's disease (AD) early for treatment. The...
The aging society urgently requires scalable methods to monitor cognitive decline and identify social and psychological factors indicative of dementia...
Exploiting deep learning methods to accelerate the analysis of medical images and the interpretation of pathology results for early diagnosis of Alzhe...
BACKGROUND: High-throughput technologies now produce a wide array of omics data, from genomic and transcriptomic profiles to epigenomic and proteomic ...
Behavioural and psychological symptoms of dementia pose challenges to the safety and well-being of individuals in residential care. The integration of...
This study utilized a novel Proximity Barcoding Assay to perform high-resolution proteomic profiling of individual plasma extracellular vesicles from ...
Alzheimer's disease (AD) is an irreversible neurodegenerative disorder. Diffusion tensor imaging (DTI) is widely used to detect brain alterations for ...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that disrupts cognitive function across multiple domains, particularly affecting ...
ObjectiveTo review the application of artificial intelligence (AI) in the care of older adults with disabilities, identifying intervention type, targe...
BACKGROUND: Counseling in family dementia care aims to support caregivers in mastering challenges. The use of information and communication technologi...
Tauopathies are characterised by a progressive accumulation of hyperphosphorylated tau. However, early and intermediate stages remain challenging to q...